Abiopharma

Published Peer-Reviewed Study Demonstrates Nexalin’s DIFS™ Neurostimulation Improves Attention and Normalizes Brain Activity in Patients with ADHD

(99% Neutral) Pulse Biosciences Inc (PLSE) Files Form 8-K

Jaguar Health Presenting January 15 at Lytham Partners Healthcare Investor Summit to Provide Updates on Near-Term Catalysts

Shareholders that lost money on agilon health, inc.(AGL) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More

Investors who lost money on Perrigo Company plc(PRGO) should contact Levi & Korsinsky about pending Class Action - PRGO

Levi & Korsinsky Notifies Shareholders of Integer Holdings Corporation(ITGR) of a Class Action Lawsuit and an Upcoming Deadline

TheraTears® Expands Dry Eye Portfolio with Two New Innovations: Eyelid Cleansing Wipes and Dry & Tired Preservative Free Lubricant Eye Drops

(80% Positive) Intuitive Surgical Inc (ISRG) Reports Q1 2026 Financial Results

CNBX Pharmaceuticals Inc. (CNBX) Files Form 10-Q

(90% Positive) ImmunityBio Inc (IBRX) Provides Update on Inhibitors for combinatio

(99% Neutral) LivaNova PLC (LIVN) Announces Executive Departure

Sellas Life Sciences - SELLAS Life Sciences Enters Agreement with IMPACT-AML to Expand SLS009 Clinical Program into Europe

Oragenics to Present at the 2026 Sequire Investor Summit in Puerto Rico

Beyond Air Announces $5.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules

(99% Neutral) Aveanna Healthcare Holdings Inc (AVAH) Reports Q1 2026 Financial Results